Список проголосовавших за комментарий " On The Wires<ul><li>Concordia International Corp. (<strong>CXRX</strong>) announced that it has paid the second and final installment of its earn-out to Cinven relating to Concordia's October 2015 acquisition of Amdipharm Mercury Limited. Today's payment of £72 million, plus interest of approximately £1.5 million, was paid with cash on hand.</li><li>Great Basin Scientific, Inc. (<strong>GBSN</strong>) announced the completion of the clinical trial and 510(k) submission to the FDA of its Bordetella Direct Test. The Company's sample-to-result test detects Bordetella pertussis directly from the patient specimen, identifying the bacterium behind the highly-contagious respiratory disease commonly known as whooping cough. The Company is also seeking a CE mark for this test.</li></ul>"